Now showing items 21-32 of 32

      Financiación
      Support from the European Commission, through the Executive Agency for Health and Consumers (EAHC, currently CHAFEA, Consumers, Health, Agriculture and Food Executive Agency, Grant Agreement n. 2007123, which made possible the realisation of the ABUEL Project, "Elder Abuse: A multinational prevalence survey." [1]
      Supported by the Spanish Ministry of Health, Instituto de Salud Carlos III, RETICS RD06/0011 (REM-TAP Network), Grant FIS 97/1298 - FIS 97/1275, Thematic network RIRAG G03/061, and RedIAPP network RD06/0018/0039. [1]
      The study in Europe was funded by a European Commission Vth Framework grant (PREDICT-QL4-CT2002-00683). Funding in Chile was provided by project FONDEF DO2I-1140. The authors are grateful for part support in Europe from: the Estonian Scientific Foundation (grant 5696); the Slovenian Ministry for Research (grant 4369-1027); the Spanish Ministry of Health (FIS references: PI041980, PI041771, PI042450) and the Spanish Network of Primary Care Research, red de Investigacion en Actividades Preventivas y Promocion de la salud (ISCIII-RETIC RD06/0018) and SAMSERAP group, and the United Kingdom National Health Service Research and Development office for service support costs in the United Kingdom. [1]
      The study is funded by the Sixth Framework of the European Commission and the authors gratefully acknowledge this support. [1]
      The study was funded by the European Commission's Fifth Framework, grant number Predict-QL4-CT2002-00683. We are also grateful for support from: the Estonian Scientific Foundation (grant number 5696); the Slovenian Ministry for research (grant No.J3-4369). [1]
      The study was funded by the Research Directorate of the European Commission within Framework Programme 5 (QLG5-CT-2002-01938). [1]
      The study was funded by the Sixth Framework of the European Commission and the authors gratefully acknowledge their support. [1]
      This research was funded by grants from the Institute Carlos III (FIS PI11/02006; FIS PI16/01029). A.G.-R. was partially funded by a private grant from the Jové family. Genotyping was partially conducted by the CEGEN-PRB2-ISCIII node, which is supported by grant PT13/001, ISCIIISGEFI/ FEDER. [1]
      This study receives funding by the Spanish Ministry of Economy, Industry and Competitiveness, Instituto Carlos III (FIS PI16/00802). [1]
      This work was mostly funded by an Andalusian Health System Health Council grant (PI0322/2009) and partially by Astra-Zeneca in agreement with CIBERSAM. It was also supported by a PhD grant from the Spanish Ministry of Education (AP2010-3563), and by the Andalusian Council of Innovation (CTS-6682). [1]
      United States Department of Health & Human Services [1]
      University of Granada CTS549 [1]